At a current share price of around $85, Chevron’s potential upside to a consensus price target of nearly $102 is 20%. Its shares traded at a multiple of nearly 30 to expected 2021 earnings, and the stock’s 52-week range is $51.60 to $122.72.
Chipmaker Intel Corp. (NASDAQ: INTC) has dropped more than 21% so far in 2020. The company’s difficulties in getting its 7-nanometer (nm) production process up and running are unlikely to be solved until late next year. In the meantime, the company reportedly has ordered 7nm chips from Taiwan Semiconductor, one of its chief rivals.
Intel stock currently trades at about $47, implying a potential upside of 10.6% to the consensus price target of $52.05. The stock trades at about 10.2 times expected 2021 earnings, and the 52-week range is $43.61 to $69.29.
Merck & Co. Inc. (NYSE: MRK) has lost about 11.5% of its market value so far in 2020. The company does not have an entry in the coronavirus pandemic vaccine space, and that could be what has kept investors wary this year. In a hopeful sign for value investors, Goldman Sachs recently raised its price target on the stock and its rating to Buy.
Merck stock trades at around $81, implying a potential upside of 18.5% to the consensus price target of $96.00. The stock’s 52-week range is $65.25 to $92.14, and shares currently trade at about 13 times expected 2021 earnings.
The only other Dow stock to have posted a loss of 10% so far this year is JPMorgan Chase & Co. (NYSE: JPM). Low interest rates have led to a decline in interest income that reached 9% in the third quarter. Higher trading revenues have helped offset the low rates, and the arrival of COVID-19 vaccines is expected to lift the bank’s credit card business next year.
JPMorgan stock trades at around $126, roughly equal to its consensus price target but nearly 12% below the 52-week high of $141.10. The stock’s 52-week low is $76.91. With expected EPS of nearly $9 in 2021, the shares trade at a multiple of 14 to their current price.